Associate Professor
Director, Outpatient Blood and Marrow Transplant Outpatient Clinic
Director, Pediatric Hematology-Oncology and Blood and Marrow Transplant Fellowship Program
Mayo Mail Code 484
420 Delaware St. SE
Minneapolis, MN 55455
Phone: (612) 626-2961
Fax: (612) 626-1434
baker084@umn.edu
Preferred method of contact: Phone
Dr. Baker is an Associate Professor of Pediatrics in the Division of Hematology-Oncology and Blood and Marrow Transplantation. He attends on the Pediatric Blood and Marrow Transplantation service. Dr. Baker is nationally recognized as an expert in the field of hematopoietic stem cell transplantation.
Dr. Baker received his M.D. degree at the University of Nebraska College of Medicine in 1988, completed his internship and residency in Pediatrics at the University of Nebraska Medical Center in 1991 and completed his post-doctoral fellowship in Hematology-Oncology at The Children's Hospital Medical Center, Cincinnati OH, in 1994. He then returned to the University of Nebraska as faculty in Pediatric Hematology-Oncology and Bone Marrow Transplant where he remained until joining the faculty at the University of Minnesota in 1997. He is board certified in Pediatrics and Hematology/Oncology.
Dr. Baker's research is focused on the use of epidemiologic methods to study treatment related acute and long-term complications in survivors after hematopoietic stem cell transplant. This research forms the basis for his current grant support in which the incidence, risk factors, and characteristics of cardiopulmonary, renal, endocrine, reproductive late effects and quality of life outcomes in long-term survivors after transplantation are being studied. Dr. Baker is also the principal investigator for several hematopoietic stem cell transplant clinical trials, particularly for treatment of children with hemophagoytic lymphohistiocytosis and other primary immune deficiencies, and also for hemoglobinopathy disorders such as sickle cell anemia and Thalassemia. For these patients, a novel type of transplantation that is designed to make transplantation for patients with these disorders safer by utilizing a reduced intensity transplant preparative regimen is being investigated. Dr. Baker is a member of the Children's Oncology Group where he serves on the Late Effects Committee, the Soft Tissue Sarcoma Committee, and the Stem Cell Transplant Committee. He also serves on the Metabolic and Immune Deficiency subcommittees of the Pediatric Blood and Marrow Transplant Consortium and the Center for International Blood and Marrow Transplant Research.
Dr. Baker has published more than 33 research papers in medical journals, including: Bone Marrow Transplantation, Blood and Journal of Clinical Oncology.
Honors and Awards
Selected Publications
Peters A, Manivel JC, Dolan M, Gulbahce HE, Baker KS, Verneris MR. Pulmonary cytolytic thrombi after allogeneic hematopoietic cell transplantation: A further histological description. Biology of Blood and Marrow Transplantation 11(6):484-485, 2005.
Ness KK, Bhatia S, Baker KS, Francisco L, Carter A, Forman SJ, Robison LL, Rosenthal J, Gurney JG. Performance limitations and participation restrictions among childhood cancer survivors treated with hematopoietic stem cell transplantation: The Bone Marrow Transplant Survivor Study. Arch Ped and Adol Med 159:706-13, 2005.
Punyko JA, Mertens AC, Baker KS, Ness KK, Robison LL, Gurney JG. Long-term survival probabilities for childhood rhabdomyosarcoma: a population-based evaluation. Cancer 103:1475-1483, 2005.
Punyko JA, Mertens AC, Gurney JG, Yasui Y, Donaldson SS, Rodeberg DA, Raney RB, Stovall M, Sklar CA, Robison LL, Baker KS. Long-term medical effects of childhood and adolescent rhabdomyosarcoma: A report from the Childhood Cancer Survivors Study. Pediatric Blood and Cancer 44:643-653, 2005.
Ness KK, Oakes JM, Punyko JA, Baker KS, Gurney JG. Prevalence of the metabolic syndrome in relation to self-reported cancer history. Annals of Epidemiology 15(3):202-206, 2004.
O'Brien TA, Eastlund T, Neglia JP, DeFor T, Abel S, Ramsay NKC, Peters C, Baker KS. Autoimmune hemolytic anemia complicating unrelated hematopoietic cell transplantation in pediatric patients: High incidence and significant mortality in patients transplanted for non-malignant diseases. British J Heamatology 127:67-75, 2004.
Baker KS, Gurney JG, Ness KK, Bhatia R, Forman SJ, Francisco L, McGlave PB, Robison LL, Snyder DS, Weisdorf DJ, Bhatia S. Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study. Blood 104(6):1898-1906, 2004.
Serna DS, Lee SJ, Zhang MJ, Baker KS, Eapen M, Horowitz MM, Klein JP, Rizzo JD, Loberiza FR Jr. Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada. J Clin Oncol 21(20):3754-3760, 2003.
Baker KS, DeFor TE, Burns LJ, Ramsay NKC, Neglia JP, Robison LL. New malignancies following blood or marrow stem cell transplantation in children and adults: Incidence and risk factors. J Clin Oncol 21(7):1352-1358, 2003.
Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, Goldman A, Kersey J, Krivit W, MacMillan M, Orchard PJ, Peters C, Weisdorf DJ, Ramsay NKC, Davies SM. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100(5):1611-1618, 2002.
Nagarajan R, Neglia J, Ramsay N, Baker KS. Successful treatment of refractory Langerhan's cell histiocytosis with unrelated cord blood transplantation. J Ped Hem Onc 23(9):629-632, 2001.
Woodard JP, Gulbahce E, Shreve M, Steiner M, Peters C, Hite S, Ramsay NKC, DeFor T, Baker KS. Pulmonary cytolytic thrombi: a newly recognized complication of stem cell transplantation. Bone Marrow Transplant. 25:293-300, 2000.
Baker KS, Gordon BG, Gross TG, Abromowitch MA, Lyden ER, Lynch JC, Vose JM, Armitage JO, Coccia PF, Bierman PJ. Autologous hematopoietic stem-cell transplantation for relapsed or refractory Hodgkin's disease in children and adolescents. J Clin Oncol. 17(3):825-831, 1999.
Baker KS, DeLaat CA, Gross TG, Shapiro, RS, Loechelt B, Steinbuch M, Harris R, Filipovich AH. Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation. Blood. 89:3857-3863, 1997.